Physician profile
Christopher K Mcspadden
NPI 1447552609
$5,291.67
in general payments reported to CMS, 2019-2025
29 companies · $2,075 in 2025
The $2,075 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $1,250 · 2022: $211 · 2023: $399 · 2024: $877 · 2025: $2,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,679 · Travel and Lodging: $1,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.20 |
| Travel and Lodging | $1,671.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Core Surgical Group | $1,105.47 | 2023-2025 | |
| Medinc of Texas | $1,093.00 | 2020 | |
| Arthrex, INC. | $880.57 | 2022-2025 | |
| Stryker Corporation | $640.44 | 2019-2025 | Prophecy, Sonicanchor, Variax |
| Organogenesis INC. | $242.02 | 2019-2023 | Puraply |
| Treace Medical Concepts, INC. | $215.67 | 2022-2025 | |
| Pylant Medical | $187.85 | 2025 | |
| Kerecis Limited | $99.87 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Bioventus LLC | $96.59 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Anika Therapeutics, INC. | $94.68 | 2023-2024 | Toe Motion, Integrity |
| Orthofix Medical, INC. | $69.03 | 2019-2020 | |
| Smith+Nephew, INC. | $59.04 | 2020-2025 | Pico |
| Depuy Synthes Sales INC. | $56.03 | 2019-2025 | |
| Ossio INC | $52.04 | 2023 | |
| Osteomed LLC | $51.52 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $47.62 | 2019 | |
| Medtronic, INC. | $42.68 | 2023-2025 | Vanta Adaptivestim, Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $32.80 | 2025 | |
| Paragon 28, INC. | $29.93 | 2019-2020 | |
| Melinta Therapeutics, LLC | $29.73 | 2019 | |
| Axogen | $26.70 | 2019 | |
| Wright Medical Technology, INC. | $26.34 | 2019-2020 | |
| Zyla Life Sciences, INC. | $19.61 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $17.64 | 2023 | Seglentis |
| Abbott Laboratories | $16.37 | 2025 | Proclaim |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.12 | 2023 | Jublia |
| Grt US Holding, INC. | $15.71 | 2020 | |
| Nevro Corp. | $13.30 | 2022 | |
| Arthrosurface Incorporated | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mcspadden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.